CIK 0001637715
- Emerging growth company
OnKure Therapeutics, Inc.
Sign in to watch- Ticker
- OKUR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472309515
- Phone
- +1 720-307-2892
- Business address
- 6707 WINCHESTER CIRCLE, SUITE 400, BOULDER, CO, 80301
- Former names
- Reneo Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,157
- in 2 filings
Net −$1,157. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-21 | Leverone Jason A. Chief Financial Officer | Sale | −302 | $2.97 | $898 | 18,500 |
| 2026-08-07 | Leverone Jason A. Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2026-08-07 | Leverone Jason A. Chief Financial Officer | Returned to the company · Employee Stock Option (right to buy | −5,781 | 0 | ||
| 2026-08-07 | Leverone Jason A. Chief Financial Officer | Grant or award · Employee Stock Option (right to buy | +5,781 | 5,781 | ||
| 2026-08-07 | Leverone Jason A. Chief Financial Officer | Returned to the company · Employee Stock Option (right to buy) | −5,322 | 0 | ||
| 2026-08-07 | Leverone Jason A. Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +5,322 | 5,322 | ||
| 2026-08-07 | Leverone Jason A. Chief Financial Officer | Returned to the company · Employee Stock Option (right to buy) | −130,611 | 0 | ||
| 2026-08-07 | Leverone Jason A. Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +130,611 | 130,611 | ||
| 2026-06-22 | Leverone Jason A. Chief Financial Officer | Sale | −303 | $4.40 | $1K | 18,802 |
| 2026-04-01 | Leverone Jason A. Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +110,000 | 110,000 | ||
| 2026-03-23 | Leverone Jason A. Chief Financial Officer | Sale | −301 | $4.16 | $1K | 16,000 |
| 2025-12-22 | Leverone Jason A. Chief Financial Officer | Sale | −302 | $2.97 | $896 | 16,301 |
| 2025-09-22 | Leverone Jason A. Chief Financial Officer | Sale | −303 | $2.62 | $795 | 12,603 |
| 2025-06-23 | Leverone Jason A. Chief Financial Officer | Sale | −303 | $2.38 | $722 | 12,906 |
| 2025-04-07 | Leverone Jason A. Chief Financial Officer | Sale | −1,844 | $2.67 | $5K | 13,209 |
| 2025-04-04 | Leverone Jason A. Chief Financial Officer | Sale | −1,278 | $3.33 | $4K | 15,053 |
| 2025-01-27 | Leverone Jason A. Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +65,000 | 65,000 | ||
| 2024-10-04 | Leverone Jason A. Chief Financial Officer | Grant or award | +16,331 | 16,331 | ||
| 2024-10-04 | Leverone Jason A. Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +5,781 | 5,781 | ||
| 2024-10-04 | Leverone Jason A. Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +5,322 | 5,322 |
Page 1 of 2 · 21 trades